Optimizing thiopurine therapy in autoimmune hepatitis: A multi-center study on monitoring metabolite profiles and co-therapy with allopurinol

Post time 2024-6-17 09:34:55

journal：Hepatology

Authors：Jan Philipp Weltzsch; Claudius F. Bartel; Moritz Waldmann; Thomas Renné; Stephanie Schulze; Benedetta Terziroli Beretta-Piccoli; Maria Papp; Oo Ye; Ronca; Marcial Sebode; Ansgar W. Lohse; Christoph Schramm; Johannes Hartl

Published date：--

DOI：10.1097/hep.0000000000000940

PDF link：https://journals.lww.com/10.1097/HEP.0000000000000940

Article link：http://dx.doi.org/10.1097/hep.0000000000000940

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time 2024-6-17 09:34:56

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Ovid] Optimizing thiopurine therapy in autoimmune hepatitis: A multi-center study on monitoring metabolite profiles and co-therapy with allopurinol

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Ovid] Optimizing thiopurine therapy in autoimmune hepatitis: A multi-center study on monitoring metabolite profiles and co-therapy with allopurinol Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Ovid] Optimizing thiopurine therapy in autoimmune hepatitis: A multi-center study on monitoring metabolite profiles and co-therapy with allopurinol